Using a provisional rather than a planned two-stent strategy for coronary bifurcation stenting may halve long-term mortality, pooled study data show. Five-year mortality was 3.8% in the 447 patients ...
SAN FRANCISCO — A sirolimus-eluting balloon was found to be noninferior to conventional stenting in separate trials of patients undergoing percutaneous coronary interventions (PCIs), suggesting these ...
TCT 362: The Impact of COVID-19 Pandemic on Unprotected Left Main Stem Percutaneous Coronary Intervention (LMSPCI) Practice: A Single-Center Experience Receive the the latest news, research, and ...
TCT 604: Evaluation of Coronary Microvascular Dysfunction in Patients With Chronic Kidney Disease Presenting With Angina With Nonobstructive Coronary Arteries Receive the the latest news, research, ...
Clinical Trials Arena on MSN
Artivion’s aortic stents boost post-surgical outcomes in interventional studies
Two of the company’s aortic stents have displayed potential to improve patient outcomes post-surgery.
As the division chief of cardiovascular medicine for the University of Kansas Health System, Dr. Mark Wiley is no stranger to stent procedures. This week, Dr. Wiley spoke with The Star to explain the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results